thrombosis
Crystal Structure Of Blood Clotting Factor Uncovered
The crystal structure of tissue-type plasminogen activator could lead to the development of new thrombolytic drugs with higher efficacy and lower side effects.
Sea Cucumber Saccharide Could Make Safe Anticoagulant
Researchers have identified an oligosaccharide that can selectively inhibit the rate-limiting enzyme of the blood coagulation cascade.
The Real Target Of Miscarriage & Thrombosis Autoantibodies
Over 80 percent of patients with antiphospholipid syndrome have autoantibodies against β2GPI in complex with HLA II.
One Receptor, Two Disparate Binding Sites
The unusual dual binding sites of the GPCR P2Y1R could lead to new blood clotting drugs.
South Korea’s Ildong Pharma To License Arena Pharma Drug
Arena Pharma has licensed its thrombosis drug to Seoul-based Ildong Pharma for further clinical testing and development in South Korea.
